How are collaborations between
DeNDRoN and industry established?
DeNDRoN offers two levels of service to support start up of an industry trial, as well as general advice for running clinical research in Dementia, Parkinson’s Disease, Motor Neurone Disease & Huntington’s Disease.
The sponsor should make initial approaches to the co-ordinating centre, to discuss the role of DeNDRoN in supporting clinical research and discuss any non-study specific requirements.
An NIHR confidentiality agreement must then be agreed, to meet all parties’ requirements and signed off with the NIHR industry team, in order to transfer confidential documents and discuss study requirements in detail.
This agreement is necessary if you wish the study to undergo any review, prior to study adoption.